François Goehringer

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites et al. · The Lancet Infectious Diseases · 2021 · 338 citations · Full text

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

Florence Ader, Nathan Peiffer‐Smadja, Julien Poissy et al. · Clinical Microbiology and Infection · 2021 · 102 citations · Full text

Clinical Infectious Disease, Open-label Randomized, Antiviral Drug Development +6

Neurological manifestations of COVID-19 in adults and children

Sung‐Min Cho, Nicole White, Lavienraj Premraj et al. · Brain · 2022 · 83 citations · Full text

Virus Epidemiology, Covid-19 Epidemiology, Covid-19 +21

Time to blood culture positivity: An independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia

S. Siméon, Vincent Le Moing, Sarah Tubiana et al. · Clinical Microbiology and Infection · 2018 · 75 citations · Full text

Culture Positivity, Independent Predictor, Healthcare-associated Infection +6

Causes of Death in HIV-Infected Individuals with Immunovirologic Success in a National Prospective Survey

François Goehringer, Fabrice Bonnet, Dominique Salmon et al. · AIDS Research and Human Retroviruses · 2016 · 73 citations

Primary Immunodeficiency, Hiv-infected Individuals, Cardiovascular Disease +14